Acadian Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Sell |
|
|||||
|
2025
Q1 | $778K | Buy |
|
|||||
|
2024
Q4 | $135K | Sell |
|
|||||
|
2024
Q3 | $235K | Sell |
|
|||||
|
2024
Q2 | $843K | Sell |
|
|||||
|
2024
Q1 | $4.28M | Buy |
|
|||||
|
2023
Q4 | $3.52M | Sell |
|
|||||
|
2023
Q3 | $4.88M | Sell |
|
|||||
|
2023
Q2 | $8.24M | Sell |
|
|||||
|
2023
Q1 | $5.72M | Buy |
|
|||||
|
2022
Q4 | $4.08M | Buy |
|
|||||
|
2022
Q3 | $3.31M | Buy |
|
|||||
|
2022
Q2 | $2.24M | Buy |
|
|||||
|
2022
Q1 | $1.89M | Sell |
|
|||||
|
2021
Q4 | $1.48M | Sell |
|
|||||
|
2021
Q3 | $2.03M | Buy |
|
|||||
|
2021
Q2 | $2.75M | Buy |
|
|||||
|
2021
Q1 | $2.32M | Buy |
|
|||||
|
2020
Q4 | $741K | Buy |
|
|||||
|
2020
Q3 | $238K | Sell |
|
|||||
|
2020
Q2 | $2.24M | Sell |
|
|||||
|
2020
Q1 | $2.11M | Buy |
|
|||||
|
2019
Q4 | $2.63M | Buy |
|
|||||
|
2019
Q3 | $867K | Sell |
|
|||||
|
2019
Q2 | $1.92M | Buy |
|
|||||
|
2019
Q1 | $890K | Buy |
|
|||||
|
2018
Q4 | $433K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $640K | Buy |
|
|||||
|
2018
Q1 | $60K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $20K | Buy |
|
|||||
|
2016
Q1 | $11K | Buy |
|